Management of Polycystic Ovarian Syndrome (PCOS)

Authors

  • Vidhi Ramesh Parakhiya Research Scholar, Master of Computer Application, Thakur Institute of Management Studies, Career Development & Research (TIMSCDR), Mumbai, Maharashtra, India.
  • Deepali S Parab Research Scholar, Master of Computer Application, Thakur Institute of Management Studies, Career Development & Research (TIMSCDR), Mumbai, Maharashtra, India

Abstract

The complex condition known as polycystic ovarian syndrome (PCOS) is characterized by chronic anovulation and hyperandrogenism. Depending on diagnostic criteria, 6–20% of females in reproductive age are afflicted. PCOS symptoms start to appear in the early pubertal years. Acne, anovulation, and irregular menstrual periods are features of PCOS and pubertal development in the average girl. The complex intertwined pathophysiology makes it difficult to identify the provoking factors. Most available scientific information communicates findings and outcomes in person to women. Different diagnostic criteria for PCOS in adolescent females have been defined, despite the Rotterdam guidelines for girls being frequently used. Menstrual irregularity, scientific hyperandrogenism, and/or hyperandrogenemia are diagnostic indicators in adolescent girls. Pelvic ultrasound findings aren't wanted for the diagnosis of PCOS in adolescent ladies.

References

Renato Pasquali, et al. PCOS Forum: Research in Polycystic Ovary Syndrome Today and Tomorrow. Clin Endocrinol (Oxf). 2011 Apr; 74 (4): 424–433.

Adam Balen. Surgical treatment of polycystic ovary syndrome. Best Pract Res Clin Endocrinol Metab.2006 Jun; 20 (2): 271–80.

National Institute of Environmental Health Sciences (NIH). NIH Study Solves Ovarian Cell Mystery, Shedding New Light on Reproductive Disorders. (May 6, 2015) by Robin Arnette, NIEHS (919) 541–5143. Available online at: https://www.niehs.nih.gov/news/newsroom/

releases/2015/may6/index.cfm

National Institute of Environmental Health Sciences (NIH).NIH Clinical Research.Last Reviewed: April 06, 2021. Available online at: https://www.niehs.nih.gov/research/clinical

/index.cfm

NIH. ClinicalTrials.gov is a database of privately and publicly funded clinical studies conducted around the world. Available online at: https://clinicaltrials.gov/ct2/home

OASH. Polycystic ovary syndrome. Page last updated: February 22, 2021. Available online at: https://www.womenshealth.gov/a-z-topics/polycystic-ovary-syndrome

Erin K Barthelmess, et al. Polycystic ovary syndrome: current status and future perspective. Front Biosci (Elite Ed). 2014 Jan 1; 6 (1): 104–19. doi: 10.2741/e695.

Medscape. Polycystic Ovarian Syndrome. Updated: Sep 19, 2019 by Richard Scott Lucidi, et al. Available online at: https://emedicine.medscape.com/article/256806-overview

Adam H. Balen, et al. Polycystic Ovary Syndrome: A Guide to Clinical Management. CRC Press; 1st edition (5 September 2019).

Wikipedia. Polycystic ovary syndrome. (19 July 2022). Available online at: https://en.wikipedia.org/wiki/Polycystic_ovary_syndrome.

Downloads

Published

2022-07-13

Issue

Vol. 11 No. 2 (2022)

Section

Review Article

License

Declaration and Copyright Transfer Form

(to be completed by authors)

I/ We, the undersigned author(s) of the submitted manuscript, hereby declare, that the above manuscript which is submitted for publication in the STM Journals(s), is not published already in part or whole (except in the form of abstract) in any journal or magazine for private or public circulation, and, is not under consideration of publication elsewhere.

  • I/We will not withdraw the manuscript after 1 week of submission as I have read the Author Guidelines and will adhere to the guidelines.
  • I/We Author(s ) have niether given nor will give this manuscript elsewhere for publishing after submitting in STM Journal(s).
  • I/ We have read the original version of the manuscript and am/ are responsible for the thought contents embodied in it. The work dealt in the manuscript is my/ our own, and my/ our individual contribution to this work is significant enough to qualify for authorship.
  •  I/We also agree to the authorship of the article in the following order:

Author’s name                                    

 

1. ________________

2. ________________

3. ________________

4. ________________

 

We  Author(s) tick this box and would request you to consider it as our signature as we agree to the terms of this Copyright Notice, which will apply to this submission if and when it is published by this journal.